Hong Kong stock market anomaly | CanSino Biologics (06185.HK) surged more than 8% in the morning, with first-half losses narrowing by over 90%. Meningitis combined vaccine has been commercialized domestically.

According to the Jrj.com.cn app, Kangxinuo Biotech (06185.HK) surged more than 8% in the morning, at the time of publication, up 8.05% to 52.75 Hong Kong dollars, with a turnover of 95.46 million Hong Kong dollars.